Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammation and prostate cancer.

Linda M Sugar1

  • 1Department of Pathology, University of Toronto, Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario, Canada.

The Canadian Journal of Urology
|March 11, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A combination of desmopressin and docetaxel inhibit cell proliferation and invasion mediated by urokinase-type plasminogen activator (uPA) in human prostate cancer cells.

Biochemical and biophysical research communications·2015
Same author

Capsaicin reduces the metastatic burden in the transgenic adenocarcinoma of the mouse prostate model.

The Prostate·2015
Same author

Micronutrients attenuate progression of prostate cancer by elevating the endogenous inhibitor of angiogenesis, platelet factor-4.

BMC cancer·2010
Same author

A combination of micronutrients is beneficial in reducing the incidence of prostate cancer and increasing survival in the Lady transgenic model.

Cancer prevention research (Philadelphia, Pa.)·2009
Same author

Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts.

Journal of the National Cancer Institute·2007
Same author

Antioxidants block prostate cancer in lady transgenic mice.

Cancer research·2004

Prostate inflammation may drive prostate cancer development. Research suggests inflammation causes cell damage and creates a microenvironment that promotes cancer growth, highlighting potential prevention strategies.

Area of Science:

  • Urology
  • Oncology
  • Pathology

Background:

  • Emerging evidence links prostate inflammation to prostate cancer development.
  • Chronic inflammation is a known factor in malignancies of other organs.
  • Inflammation may promote cancer through cell damage, increased cell turnover, and altered tissue microenvironments.

Purpose of the Study:

  • To explore the role of prostate inflammation in prostatic carcinogenesis.
  • To review epidemiological and molecular evidence supporting the inflammation-prostate cancer link.
  • To discuss the potential of targeting inflammation for prostate cancer prevention and treatment.

Main Methods:

  • Review of epidemiological studies correlating prostatitis, STDs, and anti-inflammatory drug use with prostate cancer risk.

Related Experiment Videos

  • Analysis of molecular and genetic studies investigating the link between inflammation/infection and prostate cancer.
  • Examination of the proposed role of proliferative inflammatory atrophy (PIA) as a precursor lesion.

    • Main Results:

    • Epidemiological data suggest increased prostate cancer risk with prostatitis and STDs, and decreased risk with anti-inflammatory drugs.
    • Molecular evidence supports the hypothesis that prostate inflammation or infection can cause prostate cancer.
    • The proliferative inflammatory atrophy (PIA) model suggests a pathway from inflammation to precancerous lesions and cancer.

    Conclusions:

    • Prostate inflammation is increasingly recognized as a significant factor in prostate cancer development.
    • Understanding the mechanisms of inflammation-induced carcinogenesis is crucial for developing novel therapeutic and preventive strategies.
    • Further research into the inflammatory pathways involved in prostate cancer holds promise for future interventions.